UNSPSC 51263139: Metoprolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C15H25NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GEB06NHM23, chemically known as 2-propanol, 1-(4-(2-methoxyethyl)phenoxy)-3-((1-methylethyl)amino)- but generally known as metoprolol, which bears US NIH Compound Identifier 4171. European Medicines Agency schedules Metoprolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14568MIG. The term METOPROLOL is an International Non-Proprietary Name.

UNSPSC 51263139 Metoprolol, a Commodity code, nominally names a beta-blocker pharmaceutical but shows little relevant recent state and local procurement activity under that descriptor. The single posted opportunity—Seminole County, Florida's IFB for naloxone and drug deactivation systems—does not represent metoprolol purchasing. State and local procurement under this code does not appear active in the current market window.

No further detail supports a meaningful characterization of issuing-body types, geographic spread, or representative ongoing solicitation patterns for metoprolol itself. The mismatch between the code's nominal scope and actual posted activity suggests either miscoding of the opportunity or minimal state and local demand for this specific pharmaceutical at present.